高血浆25-羟基维生素D与非黑色素瘤皮肤癌风险升高的孟德尔随机化研究
该研究纳入丹麦普通人群103 084人,其中35 298人测定了血浆25(OH)D,97 849人进行了DHCR7和CYP2R1附近四个遗传变异的分型。
要点
- 遗传决定的25(OH)D水平升高20 nmol/L与NMSC风险无显著因果关联。
- 观察性关联可能反映阳光暴露混杂而非维生素D的因果效应。
核心结论
- 遗传决定的高25(OH)D水平不保护非黑色素瘤皮肤癌,观察性高风险可能由阳光暴露混杂所致。
研究设计与样本
- 研究纳入丹麦普通人群103 084人,其中35 298人测定血浆25(OH)D,97 849人对DHCR7和CYP2R1附近四个遗传变异进行基因分型。
- 采用工具变量法(孟德尔随机化)检验遗传决定的25(OH)D水平与NMSC的关联,并与观察性关联比较。
临床怎么用
- 临床解读高血浆25(OH)D与皮肤癌风险关联时需考虑阳光暴露混杂,不宜据此推断维生素D的致癌作用。
- 孟德尔随机化结果不支持通过升高25(OH)D来预防非黑色素瘤皮肤癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High plasma 25-hydroxyvitamin D [25(OH)D] concentration has been associated observationally with a high risk of nonmelanoma skin cancer (NMSC), whereas many studies suggest that vitamin D could have a protective effect against cancer. The true association between vitamin D and risk of skin cancer remains unclear. OBJECTIVES: To test the hypothesis that genetically high plasma 25(OH)D protects against NMSC. METHODS: We included 103 084 individuals from the Danish general population, of whom 35 298 had plasma 25(OH)D measured and 97 849 were genotyped for four genetic variants near DHCR7 and CYP2R1 associated with 25(OH)D concentrations. We tested the association between plasma 25(OH)D levels and NMSC observationally and between genetically determined 25(OH)D levels and NMSC, using an instrumental variable approach. RESULTS: Multivariate-adjusted hazard ratios of NMSC were 3·27 [95% confidence interval (CI) 2·22-4·84] for plasma 25(OH)D ≥ 50 nmol L-1 vs. < 25 nmol L-1 . Genetic variants around DHCR7 and CYP2R1 were associated with up to 8·2 nmol L-1 higher 25(OH)D concentrations (F = 314). The odds ratio (OR) for a genetically determined 20 nmol L-1 higher plasma 25(OH)D was 1·11 (95% CI 0·91-1·35) for NMSC, with a corresponding observational multivariable adjusted OR of 1·13 (95% CI 1·10-1·17). CONCLUSIONS: Genetically determined high 25(OH)D levels did not appear to protect against NMSC, whereas high plasma 25(OH)D concentrations were associated with an observational high risk of NMSC. Thus, the observational association likely reflects confounding by sun exposure rather than causality.
引用
- Winsløw UC, Nordestgaard BG, Afzal S, et al. High plasma 25-hydroxyvitamin D and high risk of nonmelanoma skin cancer: a Mendelian randomization study of 97 849 individuals. Br J Dermatol. 2018. PMID: 29143981. doi:10.1111/bjd.16127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。